Digital Cognitive-Behavioral Therapy for Cardiac Anxiety After Acute Coronary Syndrome

Can Digital CBT Change Cardiac Care?

Digital Exposure-Based Cognitive-Behavioral Therapy Shows Promise for Post-ACS Cardiac Anxiety

A groundbreaking randomized controlled trial currently underway in Sweden is investigating whether exposure-based cognitive-behavioral therapy can effectively reduce cardiac anxiety in patients who have experienced acute coronary syndrome. The innovative study compares a specialized digital cognitive-behavioral therapy intervention against an active control condition, potentially offering new insights into addressing psychological distress that often accompanies cardiac events.

Acute coronary syndrome (ACS), which includes unstable angina and myocardial infarction, represents a significant health burden globally. Beyond the physical impact, approximately one-third of patients develop clinically significant cardiac anxiety following ACS. This condition manifests as excessive fear of recurrence, heightened attention to cardiac-related sensations, and avoidance behaviors related to physical activity and other situations perceived as threatening. Research has linked cardiac anxiety to poorer quality of life, development of depressive symptoms, and even adverse cardiac prognosis. Perhaps most concerning, cardiac anxiety can become a substantial barrier to engaging in crucial health behaviors, including physical activity and participation in cardiac rehabilitation programs.

How Is the Trial Designed to Address Cardiac Anxiety?

The study, led by researchers from Karolinska University Hospital, employs a rigorous two-arm parallel-group design that aims to include 176 participants nationwide in Sweden. Participants are randomized to receive either Cardiac Anxiety Cognitive-Behavioral Therapy (CA-CBT) or a Cardiac Lifestyle Intervention (CLI) over an eight-week period. Both interventions are delivered digitally through a secure platform and include regular support from clinical psychologists. The primary outcome measure is the change in cardiac anxiety as measured by the Cardiac Anxiety Questionnaire (CAQ) over the intervention period, with multiple secondary outcomes including disease-specific quality of life, physical activity levels measured through both self-report and objective accelerometry, and various psychological parameters.

What distinguishes this trial from previous research is its use of an active attention control condition matched in duration, format, and delivery mode to isolate the specific effects of exposure-based techniques. While both interventions include educational components about ACS and therapist support, the CA-CBT focuses specifically on exposure to cardiac sensations and feared situations, while the CLI emphasizes lifestyle modifications and general psychological support without exposure elements. This design allows researchers to determine whether the exposure component specifically provides added value beyond general therapeutic factors like attention and support.

The CA-CBT intervention targets three key aspects of cardiac anxiety: fear of ACS recurrence, hypervigilance related to cardiac sensations, and avoidance behaviors. It employs multiple therapeutic components including education on emotional reactions following ACS, techniques for neutral labeling of bodily sensations, interoceptive exposure to cardiac-related sensations, in vivo exposure to anxiety-provoking situations, reduction of safety behaviors, and relapse prevention strategies. In contrast, the CLI provides education on ACS, lifestyle recommendations, general behavioral change strategies, and basic guidance on managing common emotional reactions without the specific exposure framework.

Safety considerations have been carefully integrated into the study design. Participants must be at least six months post-ACS event to ensure medical stability, and comprehensive screening by both cardiac nurses and cardiologists confirms that participation poses no risk. Both interventions include guidance on distinguishing between benign and acute cardiac symptoms and when to seek medical care. Additionally, the multidisciplinary nature of the research team enables close collaboration between psychologists, cardiac nurses, and cardiologists throughout the intervention period.

Are Digital Innovations Enhancing Patient Access?

The digital delivery format represents an important innovation that may increase accessibility while reducing participant burden. All assessments are performed remotely, with data collection conducted digitally and automated reminders supporting timely completion. This approach aligns with broader trends toward digital health interventions and may provide a scalable model for addressing psychological needs in cardiac populations that traditionally face barriers to accessing mental health services.

Could this approach represent a meaningful shift in how we conceptualize comprehensive care following acute cardiac events? The integration of targeted psychological interventions addressing cardiac-specific anxiety might significantly enhance traditional cardiac rehabilitation programs. By directly targeting the fear and avoidance that often undermine adherence to physical activity and other lifestyle recommendations, such interventions could potentially improve both psychological well-being and physical health outcomes.

What might be particularly valuable about the exposure-based approach is its direct confrontation of the avoidance behaviors that can severely limit quality of life and health-promoting activities. Rather than simply providing education or general psychological support, exposure techniques systematically help patients tolerate and overcome their fears related to cardiac sensations and activities. This mechanism may prove especially important for those whose cardiac anxiety significantly interferes with their recovery and daily functioning.

The findings from this study could have substantial implications for clinical practice. If the CA-CBT demonstrates superior efficacy compared to the active control, it would provide strong evidence for incorporating exposure-based techniques specifically targeting cardiac anxiety into standard post-ACS care. This could lead to more widespread implementation of digital CBT interventions as adjuncts to traditional cardiac rehabilitation, potentially improving both psychological outcomes and physical recovery through increased engagement in health behaviors.

How might healthcare systems best implement such interventions if proven effective? The digital format offers obvious advantages for scalability and accessibility, but questions remain about optimal integration with existing cardiac care pathways, appropriate patient selection, and necessary adaptations for diverse populations. The study's focus on patients with clinically significant cardiac anxiety ensures targeting of those most likely to benefit, but broader implementation would require careful consideration of screening approaches and potential modifications for various clinical contexts.

What Could This Mean for Future Clinical Practice?

The ongoing trial represents a significant step forward in addressing the psychological aspects of cardiac recovery that have often been neglected in traditional care models. By rigorously testing a specialized intervention against an active control, the researchers are generating valuable evidence that could inform more holistic approaches to post-ACS care. The results, expected in 2026, will provide important insights into whether exposure-based digital CBT offers meaningful advantages over general lifestyle and psychological support for patients experiencing cardiac anxiety following ACS.

What additional psychological mechanisms might explain the relationship between cardiac anxiety and poorer outcomes in ACS patients? Beyond avoidance behaviors, how might catastrophic interpretations of bodily sensations, hypervigilance, and safety behaviors contribute to a cycle that maintains both psychological distress and potentially influences physiological parameters? These questions highlight the complexity of the mind-body relationship in cardiac conditions and underscore the importance of targeted interventions addressing these specific psychological processes.

The study's methodological strengths, including blinded participants, matched intervention formats, and objective physical activity measurement, provide a solid foundation for evaluating the specific contribution of exposure techniques. By controlling for non-specific therapeutic factors, the researchers can more confidently attribute any observed differences to the active components of the exposure-based intervention rather than general factors like attention, support, or expectancy effects.

As healthcare increasingly recognizes the importance of addressing psychological factors in chronic disease management, studies like this offer valuable models for developing and testing targeted interventions that address condition-specific psychological challenges. The results will not only inform post-ACS care specifically but may also provide insights relevant to psychological interventions for other cardiac conditions and chronic diseases more broadly.

The study builds upon promising preliminary work, including two pilot studies and a previous randomized controlled trial comparing CA-CBT to usual care, which demonstrated substantial reductions in cardiac anxiety and improvements in quality of life. This current trial addresses a key limitation of the previous research by including an active control condition rather than comparing the intervention to usual care alone. The CA-CBT intervention was initially developed for patients with atrial fibrillation and has been further adapted specifically for the post-ACS population based on feedback from participants in earlier studies.

Statistical analysis will employ linear mixed-effects models with random intercepts to analyze changes in cardiac anxiety scores over the 10-week measurement period (baseline, 8 weekly assessments, and post-intervention). This approach allows for the inclusion of all randomized participants according to the intention-to-treat principle while accounting for the longitudinal nature of the data. Effect sizes will be calculated as the standardized mean difference at post-intervention based on baseline standard deviation.

The study's recruitment began in March 2024 and had enrolled 81 participants as of June 2025, with enrollment continuing until the target of 176 participants is reached. The recruitment strategy includes nationwide self-referral through social media, press advertisements, and information distributed to cardiology clinics, medical clinics, and primary care units throughout Sweden. This approach aims to ensure a diverse and representative sample of post-ACS patients experiencing cardiac anxiety.

Will These Findings Shape Screening and Regulatory Policies?

Could the findings from this trial influence future screening practices for cardiac anxiety in routine post-ACS care? If effective, might brief screening for cardiac anxiety become a standard component of follow-up assessments, allowing for more targeted referrals to psychological interventions? The development of efficient clinical pathways that integrate psychological and physical aspects of recovery represents an important challenge for comprehensive cardiac care.

What regulatory challenges might arise in implementing digital therapeutic interventions across different healthcare systems? While the digital format offers advantages for scalability, questions regarding reimbursement, licensure across jurisdictions, and integration with electronic health records will need to be addressed to facilitate widespread implementation if the intervention proves effective.

As the trial progresses toward completion, it offers hope for a more comprehensive approach to post-ACS care that addresses both the physical and psychological aspects of recovery. By targeting cardiac anxiety specifically, rather than general psychological distress, the intervention has the potential to address a significant barrier to optimal outcomes for many cardiac patients. The results of this methodologically rigorous trial will provide valuable guidance for clinicians and healthcare systems seeking to enhance the quality and comprehensiveness of post-ACS care.

Summary

A Swedish randomized controlled trial is investigating whether digital exposure-based cognitive-behavioral therapy can effectively reduce cardiac anxiety in patients who have experienced acute coronary syndrome. Approximately one-third of patients develop clinically significant cardiac anxiety following acute coronary syndrome, which manifests as excessive fear of recurrence, heightened attention to cardiac sensations, and avoidance of physical activity. This condition is associated with poorer quality of life, depressive symptoms, and adverse cardiac outcomes. The study compares a specialized Cardiac Anxiety Cognitive-Behavioral Therapy intervention against an active Cardiac Lifestyle Intervention control, both delivered digitally over eight weeks to 176 participants nationwide. The cognitive-behavioral therapy focuses on exposure to cardiac sensations and feared situations, while the control emphasizes lifestyle modifications without exposure elements. This design allows researchers to determine whether exposure techniques provide added value beyond general therapeutic support. The digital format may increase accessibility and reduce participant burden, potentially offering a scalable model for addressing psychological needs in cardiac populations. Safety measures include enrollment only of patients at least six months post-event and comprehensive medical screening. Previous pilot studies demonstrated substantial reductions in cardiac anxiety and improvements in quality of life. Results expected in 2026 could inform more holistic approaches to post-acute coronary syndrome care and potentially lead to incorporation of exposure-based techniques into standard cardiac rehabilitation programs.